title: Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
authors.forename: Gianluigi
authors.initials: G
authors.lastname: Ferretti
authors.forename: Emilio
authors.initials: E
authors.lastname: Bria
authors.forename: Diana
authors.initials: D
authors.lastname: Giannarelli
authors.forename: Paolo
authors.initials: P
authors.lastname: Carlini
authors.forename: Alessandra
authors.initials: A
authors.lastname: Felici
authors.forename: Mario
authors.initials: M
authors.lastname: Mandala
authors.forename: Paolo
authors.initials: P
authors.lastname: Papaldo
authors.forename: Cecilia
authors.initials: C
authors.lastname: Nistico
authors.forename: Alessandra
authors.initials: A
authors.lastname: Fabi
authors.forename: Federica
authors.initials: F
authors.lastname: Cuppone
authors.forename: Alain
authors.initials: A
authors.lastname: Gelibter
authors.forename: Edmondo
authors.initials: E
authors.lastname: Terzoli
authors.forename: Francesco
authors.initials: F
authors.lastname: Cognetti
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D015897:Comorbidity; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D013923:Thromboembolism / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight